Advertisement
Screener

QUIDELORTHO CORP (QDEL) Graph

1.5 / 5 stars · 20/68 Roast Me

Add as a preferred source on Google

QDEL Revenue Flow

Filed revenue amounts for 2026-03-30 to 2026-06-28. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-28: Revenue $630.90M; Research and development $48.70M; Selling, general and administrative $189.70M; Income tax $11.70M.
  • 2026-03-29: Revenue $619.80M; Research and development $44.90M; Selling, general and administrative $199.30M; Income tax $12.30M.
  • 2025-12-28: Revenue $723.60M*; Research and development $45.80M*; Selling, general and administrative $194.40M*; Income tax $18.30M*.
  • 2025-09-28: Revenue $699.90M; Research and development $41.50M; Selling, general and administrative $186.90M; Income tax -$23.90M.

Business Unit

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

QDEL revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Donor Screening$4.00MImmunohematology$134.20MLabs$382.90MMolecular Diagnostics$1.60MPoint Of Care$108.20MRevenue$630.90MOperating income-$21.80MOther income, net-$4.70MResearch & development$48.70MSelling, general& administrative$189.70MPre-tax income-$81.20MIncome tax$11.70MNet income-$92.90M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueResearch and developmentSelling, general and administrativeIncome taxNet income
2026-06-28$630.90M$48.70M$189.70M$11.70M-$92.90M
2026-03-29$619.80M$44.90M$199.30M$12.30M-$91.80M
2025-12-28$723.60M*$45.80M*$194.40M*$18.30M*-$130.70M*
2025-09-28$699.90M$41.50M$186.90M-$23.90M-$733.00M
2025-06-29$613.90M$45.70M$178.00M$25.80M-$255.40M
2025-03-30$692.80M$53.20M$187.00M$3.90M-$12.70M
2024-09-29$727.10M$55.90M$186.40M-$8.90M-$19.90M
2024-06-30$637.00M$56.30M$188.20M-$15.20M-$147.70M
2024-03-31$711.00M$59.20M$204.70M-$92.90M-$1.71B
2023-10-01$744.00M$61.50M$194.10M-$2.80M-$12.70M
2023-07-02$665.10M$62.40M$179.10M-$11.20M-$53.20M
2023-04-02$846.10M$62.30M$202.40M$11.20M$48.80M
2022-10-02$783.80M$65.60M$204.20M$12.10M$19.20M
2022-07-03$613.40M$34.20M$118.40M$23.60M$19.30M
2022-04-03$1.00B$26.40M$84.80M$140.70M$479.90M
2021-10-03$509.80M$23.70M$63.00M$65.80M$215.70M
2021-07-04$176.60M$22.60M$54.20M$2.60M$19.10M
2021-04-04(m)(m)(m)(m)$178.10M

Revenue and expense 6 month

Period endRevenueResearch and developmentSelling, general and administrativeIncome taxNet income
2026-06-28$1.25B$93.60M$389.00M$24.00M-$184.70M
2025-06-29$1.31B$98.90M$365.00M$29.70M-$268.10M
2024-06-30$1.35B$115.50M$392.90M-$108.10M-$1.85B
2023-07-02$1.51B$124.20M$381.50M$0.00-$4.40M
2022-07-03$1.62B$60.60M$203.20M$164.30M$499.20M
2021-07-04$551.90M$45.90M$102.90M$46.30M$197.20M

Revenue and expense 9 month

Period endRevenueResearch and developmentSelling, general and administrativeIncome taxNet income
2025-09-28$2.01B$140.40M$551.90M$5.80M-$1.00B
2024-09-29$2.08B$171.40M$579.30M-$117.00M-$1.87B
2023-10-01$2.26B$185.70M$575.60M-$2.80M-$17.10M
2022-10-02$2.40B$126.20M$407.40M$176.40M$518.40M
2021-10-03$1.06B$69.60M$165.90M$112.10M$412.90M

Revenue and expense 12 month

Period endRevenueRevenue including taxResearch and developmentSelling, general and administrativeIncome taxNet income
2025-12-28$2.73B(m)$186.20M$746.30M$24.10M-$1.13B
2024-12-29$2.78B(m)$218.70M$766.80M-$79.50M-$2.05B
2023-12-31$3.00B$3.00B$245.00M$763.20M-$19.00M-$10.10M
2023-01-01$3.27B$3.27B$187.90M$621.00M$187.20M$548.70M
2022-01-02$1.70B$1.70B$95.70M$239.60M$196.10M$704.20M
2021-01-03$1.66B$1.66B$84.30M$180.70M$230.00M$810.30M

Similar stocks

Stock NameCountryMarket CapPE Ratio
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92
Advertisement